MMP-2 and DcR3 expression in esophageal cancer tissue and correlation with patient survival

International Journal of Clinical and Experimental Medicine

Volumn 6, Issue 8, 2013, Pages 700-705

  Ao, Ran ^a   Du, Ya Qi ^a   Wang, Ying ^a   Chen, Yu Shuai ^a   Wang, Bing Yuan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Decoy receptor; Esophageal cancer; Matrix metalloproteinase 2

Indexed keywords

DECOY RECEPTOR 3; GELATINASE A;

ADULT; AGE; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CANCER TISSUE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ESOPHAGUS BIOPSY; ESOPHAGUS CARCINOMA; ESOPHAGUS SURGERY; FEMALE; GENDER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; TUMOR BIOPSY; TUMOR DIFFERENTIATION; TUMOR INVASION; TUMOR VOLUME;

EID: 84884224975     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Artandi SE, DePinho RA. Telomeres and telomerase in cancer. Carcinogenesis 2010; 31: 9-18.
2. Yang CR, Hsieh SL, HO FM, Lin WW. Decoy receptor 3 increases monocyte adhesion to endothelial cells via NF-Kappa B-dependent upregulation of intercellular adhesion molecule-1, Vcan-1, and IL-8 expression. J Immunol 2005; 174: 1647-1649.
3. Yamana K, Bilim V, Hara N. Prognostic Impact of FAS/CD95/APO-1 in urothelial cancers: decreased expression of Fas is associated with disease progression. Br J Cancer 2005; 93: 544-551.
4. Hsu TL, Wu YY, Chang YC, Yang CY, Lai MZ, Su WB, Hsieh SL. Attenuation of Th1 Response in decoy receptor 3 transgenic mice. Immunol 2005; 175: 5135-5145.
5. Chen J, Zhang L, Kim S. Quantification and detection of DcR3, a decoy receptor in TNFR family. J Immunol Methods 2004; 285: 63-70.
6. Yamashita K, Upadhay S, Mimori K, Inoue H, Mori M. Clinical significance of secreted protein acidic and rich in cystein in esophageal carcinoma and its relation to carcinoma progression. Cancer 2003; 97: 2412-2419.
7. Samantaray S, Sharma R, Chattopadhyaya TK, Gupta SD, Ralhan R. Increased expression of MMP-2 and MMP-9 in esophageal squamous cell carcinoma. Cancer Res Clin Oncol 2004; 130: 37-44.
8. Yue QF, Xiang M, Li FM. The Expression and Clinical Significance of DcR3 and MMP-2 in Esophageal Squamous Cell Carcinoma. Chin J Clinical Med 2010; 17: 655-658.
9. Quaranta M, Daniele A, Coviello M, Venneri MT, Abbate I, Caringella ME, Di Tardo S, Divella R, Trerotoli P, Di Gennaro M, Schittulli F, Fransvea E, Giannelli G. MMP-2, MMP-9, VEGF and CA 15.3 in breast cancer. Anticancer Res 2007; 27: 3593-3600.
10. Hayashi S, Miura Y, Nishiyama T, Mitani M, Tateishi K, Sakai Y, Hashiramoto A, Kurosaka M, Shiozawa S, Doita M. Decoy receptor 3 expressed in rheumatoid synovial fibroblasts protects the cells against fas-induced apoptosis. Arthritis Rheum 2007; 56: 1067-1075.
11. Zhan C, Yan Q, Patskovsky Y, Li Z, Toro R, Meyer A, Cheng H, Brenowitz M, Nathenson SG, Almo SC. Biochemical and structural characterization of the human TL1A ectodomain. Biochemistry 2009; 48: 7636-7645.
12. Li WZ, Zhang CG, Chen CX, Zhuang G. Correlation between expression of DcR3 on tumor cells and sensitivity to FasL. Cell Mol Immunol 2007; 4: 455-460.
13. Yang CR, Hsieh SL, Teng CM, Ho FM, Su WL, Lin WW. Soluable decoy receptor 3 induces angiogenesis by neutralization of TL1A, a cytokine belonging to tumor necrosis factor superfamily and exhibiting angiostatic action. Cancer Res 2004; 64: 1122-1129.
14. Connor JP, Felder M. Ascites from epithelial ovarian cancer contain high levels of functional decoy receptor 3 (DcR3) and is associated with platinum resistance. Gynecol Oncol 2008; 111: 330-335.
15. Chen C, Zhang C, Zhuang G, Luo H, Su J, Yin P, Wang J. Decoy receptor 3 overexpression and immunologic tolerance in hepatocellular carcinoma (HCC) development. Cancer Invest 2008; 26: 965-974.
16. Mrena J, Wiksten JP, Nordling S, Kokkola A, Ristimäki A, Haglund C. MMP-2 but not MMP-9 associated with COX-2 and survival in gastric cancer. J Clin Pathol 2006; 59: 618-623.
17. Macher-Goeppinger S, Aulmann S, Wagener N, Funke B, Tagscherer KE, Haferkamp A, Hohen fellner M, Kim S, Autschbach F, Schirmacher P, Roth W. Decoy receptor 3 is a prognostic factor in renal cell cancer. Neoplasia 2008; 10: 1049-1056.
18. He J, Ding JB, Yu WZ. Diagnostic value of multiple tumor markers protein biochip for patients with esophageal carcinoma. Shanxi Med J 2011; 40: 280-283.